(Q38782662)

6 September 2017

SIRT1 prevents hyperuricemia via the PGC-1α/PPARγ-ABCG2 pathway (English)

1 reference

6 September 2017

Juan Wang

1

1 reference

6 September 2017

Xiao-Xia Zhu

2

1 reference

6 September 2017

Lei Liu

3

1 reference

6 September 2017

Yu Xue

4

1 reference

6 September 2017

Xue Yang

5

1 reference

6 September 2017

He-Jian Zou

6

1 reference

6 September 2017

29 March 2016

1 reference

6 September 2017

1 reference

6 September 2017

53

1 reference

6 September 2017

2

1 reference

6 September 2017

443-452

1 reference

https://scigraph.springernature.com/pub.10.1007/s12020-016-0896-7

6 September 2017

0 references

cites work

Hyperuricemia, gout and the kidney

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

The uric acid metabolism pathway as a therapeutic target in hyperuricemia related to metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Urate transporters in the genomic era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Mechanism of human SIRT1 activation by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Nuclear control of the inflammatory response in mammals by peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Peroxisome proliferator-activated receptor gamma-regulated ABCG2 expression confers cytoprotection to human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Study on the correlation between constituents detected in serum from Rhizoma Smilacis Glabrae and the reduction of uric acid levels in hyperuricemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Two independent mutational events in the loss of urate oxidase during hominoid evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Serum uric acid-lowering therapies: where are we heading in management of hyperuricemia and the potential role of uricase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Reactive oxygen species derived from xanthine oxidase interrupt dimerization of breast cancer resistance protein, resulting in suppression of uric acid excretion to the intestinal lumen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Decreased extra-renal urate excretion is a common cause of hyperuricemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

In-vitro evidence of enhanced breast cancer resistance protein-mediated intestinal urate secretion by uremic toxins in Caco-2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Perspectives on translational and therapeutic aspects of SIRT1 in inflammaging and senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Recent progress in the biology and physiology of sirtuins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Nutrient availability regulates SIRT1 through a forkhead-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and -gamma. Identification of novel leucine-rich interaction motif within PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Fasting promotes the expression of SIRT1, an NAD+ -dependent protein deacetylase, via activation of PPARalpha in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

PPARbeta/delta regulates the human SIRT1 gene transcription via Sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Aberrant promoter methylation of the ABCG2 gene in renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Proinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NF{kappa}B cooperativity at adjacent response elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

Nuclear receptor corepressors and PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-016-0896-7

ABCG2 is a high-capacity urate transporter and its genetic impairment increases serum uric acid levels in humans

21 January 2018

1 reference

12 December 2020

The effect of resveratrol on the recurrent attacks of gouty arthritis

1 reference

12 December 2020

Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression

1 reference

12 December 2020

Anti-hyperuricemic and nephroprotective effects of Smilax china L

1 reference

12 December 2020

10.1007/S12020-016-0896-7

Identifiers

DOI

1 reference

6 September 2017

1 reference